维里西瓜特减弱了在低频范围内开放循环巴罗反射功能的动态增益
Aimi Yokoi1, Toru Kawada2, Nana Hiraki2
1Tokyo University of Agriculture and Technology, Fuchu, Tokyo, 183-8509, Japan; Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, Osaka, 564-8565, Japan.
Autonomic neuroscience : basic & clinical
|October 16, 2025
概括
维里西瓜特是一种可溶性瓜尼酸环酶刺激剂,通过增强巴罗反射反循环来改善血压调节. 这种药物减弱了动态增益,表明通过氧化路径改善了血管收缩的控制.
科学领域:
- 心血管生理学心血管生理学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 韦里西瓜特是一种可溶性瓜尼酸环酶刺激剂,可增加循环瓜诺辛单酸盐水平.
- 氧化 (NO) 在调节血管度和血压方面起着至关重要的作用.
- 頸動脈鼻氣反射是短期血壓控制的關鍵機制.
研究的目的:
- 为了研究 vericiguat对心动脉巴罗反射的动态特征的影响.
- 为了确定传感器如何影响baroreflex的神经和外围弧.
- 阐明 vericiguat在调节交感神经活动和动脉压调节中的作用.
主要方法:
- 用麻醉的威斯塔尔-京都大鼠 (n=8) 来评估巴罗反射动力学.
- 用高斯的白噪声信号来变化状鼻压力 (CSP).
- 对交感神经活动 (SNA),动脉压 (AP) 和大动脉流量进行了持续监测.
- 转移函数分析被用来比较在接受治疗前和治疗期间的巴罗反射弧.
主要成果:
- 韦里西瓜特的使用减少了外围巴罗反射弧 (SNA到AP) 中的非对称动态增益.
- 神经弧 (CSP到SNA) 的动态增益并没有受到 vericiguat.at 的显著改变.
- 维里西瓜特降低了总弧 (CSP到AP) 的非对称动态增益,并增加了它的角频率.
结论:
- 韦里西瓜特减弱了巴罗反射的动态增益,特别是在较低的频率,表明增强的反调节.
- 这些发现表明, vericiguat可以改善由内源性氧化介导的血管收缩的负反控制.
- 韦里西瓜特对巴罗反射动态的影响可能有助于其在心血管疾病中的治疗效益.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
Neural Regulation of Blood Pressure
6.8K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
6.8K
Heart Failure Drugs: β-Blockers
760
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
760
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
Hypertension II: Pathophysiology
781
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
781
Autoregulation of Blood Flow
7.4K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
7.4K


